CX3CR1 and cancer: An increase in sCX3CL1 expression in the cancer microenvironment allows the chemotaxis of all the aforementioned cells with CX3CR1 expression towards the cancer niche, where they exert an anticancer effect, with NK cells and CD8+ T cells the most significant in the direct anticancer action of CX3CL1 [61,62,63].